- Home
- MRSN vs OXSQ Comparison
MRSN vs OXSQ Comparison
Compare MRSN & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRSN | OXSQ |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 151.1M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRSN | OXSQ |
|---|---|---|
| Price | $29.10 | $1.75 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $30.38 | N/A |
| AVG Volume (30 Days) | 54.7K | ★ 819.9K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 24.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,180,000.00 | ★ $40,142,565.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.21 | $1.56 |
| 52 Week High | $40.88 | $2.87 |
Technical Indicators
Market Signals| Indicator | MRSN | OXSQ |
|---|---|---|
| Relative Strength Index (RSI) | 84.06 | 37.62 |
| Support Level | $28.85 | $1.72 |
| Resistance Level | $29.39 | $1.87 |
| Average True Range (ATR) | 0.49 | 0.04 |
| MACD | -0.53 | -0.01 |
| Stochastic Oscillator | 85.71 | 23.53 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.